Papel de los niveles circulantes del antígeno carbohidrato 125 para identificar al paciente no frágil con IC

[1]  J. Núñez,et al.  Carbohydrate antigen 125 (CA125) as a prognostic marker in the elderly with acute heart failure and preserved ejection fraction , 2022, Medicina Clínica (English Edition).

[2]  E. Orwoll,et al.  Candidate biomarkers of physical frailty in heart failure: an exploratory cross-sectional study. , 2022, European journal of cardiovascular nursing.

[3]  F. Alfonso,et al.  Fragilidad y pronóstico de los pacientes mayores con insuficiencia cardiaca. , 2022, Revista espanola de cardiologia.

[4]  A. Bayés‐Genís,et al.  Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction , 2022, Scientific reports.

[5]  A. Bayés‐Genís,et al.  Prognostic value of NT-proBNP and CA125 across glomerular filtration rate categories in acute heart failure. , 2021, European journal of internal medicine.

[6]  J. Lupón,et al.  Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review , 2021, European journal of heart failure.

[7]  J. Lupón,et al.  Punto de corte óptimo del antígeno carbohidrato 125 para la identificación de pacientes con bajo riesgo tras un ingreso por insuficiencia cardiaca aguda , 2021 .

[8]  F. Rutten,et al.  Epidemiology of heart failure , 2020, European journal of heart failure.

[9]  M. Metra,et al.  Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis. , 2020, JACC. Heart failure.

[10]  A. Pandey,et al.  Frailty Is Intertwined With Heart Failure: Mechanisms, Prevalence, Prognosis, Assessment, and Management. , 2019, JACC. Heart failure.

[11]  B. Leung,et al.  Serum Myostatin and IGF-1 as Gender-Specific Biomarkers of Frailty and Low Muscle Mass in Community-Dwelling Older Adults , 2019, The journal of nutrition, health & aging.

[12]  E. Núñez,et al.  Growth differentiation factor 15 and geriatric conditions in acute coronary syndrome. , 2019, International journal of cardiology.

[13]  M. T. Vidán,et al.  Impacto de las variables geriátricas en la mortalidad a 30 días de los ancianos atendidos por insuficiencia cardiaca aguda , 2018 .

[14]  F. Formiga,et al.  Basal functional status predicts one-year mortality after a heart failure hospitalization in elderly patients - The RICA prospective study. , 2018, International journal of cardiology.

[15]  James O. Mudd,et al.  The prevalence of frailty in heart failure: A systematic review and meta-analysis. , 2017, International journal of cardiology.

[16]  G. Sergi,et al.  Risk of cardiovascular disease morbidity and mortality in frail and pre-frail older adults: Results from a meta-analysis and exploratory meta-regression analysis , 2017, Ageing Research Reviews.

[17]  Héctor Bueno,et al.  Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica , 2016 .

[18]  S. Morell,et al.  Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study. , 2016, JACC. Heart failure.

[19]  H. Bueno,et al.  Prevalence and prognostic impact of frailty and its components in non‐dependent elderly patients with heart failure , 2016, European journal of heart failure.

[20]  C. Hermenegildo,et al.  Usefulness of Clinical Data and Biomarkers for the Identification of Frailty After Acute Coronary Syndromes. , 2015, The Canadian journal of cardiology.

[21]  F. J. Martín-Sánchez,et al.  El manejo de la insuficiencia cardiaca aguda en los servicios de urgencias hospitalarios españoles en función de la edad , 2013 .

[22]  E. Núñez,et al.  CA125 and immunoinflammatory activity in acute heart failure. , 2010, International journal of cardiology.

[23]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[24]  Héctor Bueno,et al.  Recomendaciones de la Sección de Cardiología Geriátrica de la Sociedad Española de Cardiología para la valoración de la fragilidad en el anciano con cardiopatía , 2019, Revista Española de Cardiología.

[25]  G. Fonarow,et al.  Heart Failure Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices Primary Results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) , 2010 .